Clinical Trial: 21552

Trial Status: Open
Disease Types: Solid Tumors All, Lymphoma
Trial ID 21552
Sponsor ID RGX-104-001

“A Phase 1 Study of RGX-104, a Small Molecule LXR Agonist, as a Single Agent and as Combination Therapy in Patients with Advanced Solid Malignancies and Lymphoma with an Expansion in Select Malignancies (RGX-104-001)”


Fairfax Office

Learn More About This Trial
Other Relevant Trials
Trial ID TOS-358-001
Sponsor ID Totus

A Study to Evaluate the Safety and Tolerability of the Covalent Phosphoinositide-3-Kinase (PI3K)-alpha Inhibitor, TOS-358, in Adult Subjects with Select Solid Tumors

Trial ID NP-G2-044-P2-01
Sponsor ID Novita

NP-G2-044 as Monotherapy and Combination Therapy in Patients With Advanced or Metastatic Solid Tumor Malignancies